Follow Us:
Psyllium Exporter From India

Psyllium

Psyllium is a natural soluble fibre obtained from the husks of Plantago ovata seeds and is used as a bulk-forming laxative to relieve constipation and promote regular bowel movements. It absorbs water in the intestine, forming a gel-like substance that softens stool and increases its bulk, making it easier to pass. Psyllium is available as powder, granules, capsules, and fibre-based formulations, and may also be used as part of dietary management to help lower LDL cholesterol and support blood glucose control. Common side effects include bloating, gas, and abdominal discomfort, particularly when treatment is started. It must be taken with sufficient water because inadequate fluid intake may cause choking or intestinal blockage. People with difficulty swallowing, suspected bowel obstruction, or persistent abdominal pain should seek medical advice before using it.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Psyllium

Psyllium was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Psyllium

Availability of Psyllium

Delivery of Psyllium

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Psyllium.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Psyllium.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Psyllium, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Psyllium Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Psyllium

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Psyllium Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Psyllium, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Psyllium

The export of Psyllium from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Psyllium Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Psyllium specifications, certificates of analysis, and other supporting documents required for Psyllium export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Psyllium export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Psyllium regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Psyllium documentation, labelling, Psyllium manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Psyllium Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Psyllium, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.